Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung disease.
Boyang ZhengKathryn DonohoeNathan HamblyKerri A JohannsonDeborah AssayagJolene H FisherHelene ManganasVeronica MarcouxNasreen KhalilMartin R J KolbChristopher J Ryersonnull nullPublished in: Respirology (Carlton, Vic.) (2022)
Seropositivity in non-CTD ILD was not associated with improved outcomes or treatment response, highlighting the importance of other disease features in determining prognosis and predicting response to immunosuppression.